Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$6.29M |
| 2 |
Warner Bros
WBD
|
+$1.83M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73M |
| 4 |
UnitedHealth
UNH
|
+$567K |
| 5 |
Home Depot
HD
|
+$411K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$5.75M |
| 2 |
ASML
ASML
|
+$1.66M |
| 3 |
Conagra Brands
CAG
|
+$1.54M |
| 4 |
DuPont de Nemours
DD
|
+$1.38M |
| 5 |
AT&T
T
|
+$1.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.16% |
| 2 | Healthcare | 15.51% |
| 3 | Communication Services | 14.31% |
| 4 | Consumer Staples | 13.11% |
| 5 | Financials | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
AB InBev
BUD
$155B
| $9.24M | 3.63% |
153,961
-6,246
| -4% | -$335K |
|
2
Wells Fargo
WFC
$254B
| $9.11M | 3.58% |
220,580
-6,642
| -3% | -$294K |
|
3
Kraft Heinz
KHC
$30.3B
| $9.09M | 3.57% |
223,350
-7,303
| -3% | -$277K |
|
4
Boeing
BA
$169B
| $9.08M | 3.57% |
47,676
-2,118
| -4% | -$346K |
|
5
CVS Health
CVS
$119B
| $8.91M | 3.5% |
95,635
-707
| -0.7% | -$68.2K |
|
6
Simon Property Group
SPG
$70.6B
| $8.69M | 3.41% |
73,961
-2,276
| -3% | -$253K |
|
7
Microsoft
MSFT
$3.59T
| $8.52M | 3.35% |
35,544
-926
| -3% | -$222K |
|
|
K
8
DELISTED
Kellanova
K
| $8.46M | 3.32% |
126,437
-1,132
| -0.9% | -$76.8K |
|
9
GSK
GSK
$105B
| $8.36M | 3.28% |
237,879
-6,099
| -2% | -$203K |
|
10
Biogen
BIIB
$32B
| $8.33M | 3.27% |
30,076
-1,678
| -5% | -$474K |
|
11
Enterprise Products Partners
EPD
$82.1B
| $8.27M | 3.25% |
342,945
-2,845
| -0.8% | -$70K |
|
|
12
AT&T
T
$173B
| $8.02M | 3.15% |
435,411
-71,271
| -14% | -$1.28M |
|
|
13
DuPont de Nemours
DD
$18.7B
| $7.98M | 3.14% |
92,671
-17,283
| -16% | -$1.38M |
|
14
TSMC
TSM
$2.17T
| $7.44M | 2.92% |
99,850
-2,486
| -2% | -$180K |
|
|
15
ASML
ASML
$677B
| $7.13M | 2.8% |
13,047
-3,172
| -20% | -$1.66M |
|
16
Emerson Electric
EMR
$87.7B
| $6.96M | 2.73% |
72,420
-668
| -0.9% | -$60K |
|
|
BNY
17
Bank of New York Mellon
BNY
$108B
| $6.95M | 2.73% |
152,779
-1,306
| -0.8% | -$56K |
|
18
Compass Minerals
CMP
$1.09B
| $6.76M | 2.66% |
164,812
-5,948
| -3% | -$246K |
|
|
19
Warner Bros
WBD
$71.6B
| $6.72M | 2.64% |
709,126
+161,793
| +30% | +$1.83M |
|
20
Becton Dickinson
BDX
$52.3B
| $6.7M | 2.63% |
26,335
-761
| -3% | -$180K |
|
21
Zimmer Biomet
ZBH
$19.3B
| $6.2M | 2.43% |
48,596
-10,302
| -17% | -$1.2M |
|
22
RTX Corp
RTX
$283B
| $6.14M | 2.41% |
60,795
-11,749
| -16% | -$1.11M |
|
|
23
Conagra Brands
CAG
$7.89B
| $6.04M | 2.37% |
156,148
-42,441
| -21% | -$1.54M |
|
24
Intel
INTC
$476B
| $5.98M | 2.35% |
226,245
-17,194
| -7% | -$478K |
|
25
Lam Research
LRCX
$393B
| $5.83M | 2.29% |
138,680
-4,820
| -3% | -$202K |
|
Similar funds
Mark Hillman's Q4 2022 Portfolio in Review
As of Q4 2022, Mark Hillman held 53 positions worth $255M, up 5.7% from $241M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Mark Hillman withdrew a net $10.8M in Q4 2022, closing 1 position and reducing 43 holdings. Its most notable exit was Merck, an estimated $5.75M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Mark Hillman opened a new position in Walt Disney worth $5.71M.
- Mark Hillman's largest Q4 2022 buy was Walt Disney: 65,744 shares worth $5.71M.
- Mark Hillman added most to Warner Bros in Q4 2022, an estimated $1.83M increase.
- Mark Hillman's biggest Q4 2022 reduction was ASML, cutting an estimated $1.66M.
- Mark Hillman fully exited Merck in Q4 2022, selling an estimated $5.75M.
- Mark Hillman's ten largest holdings make up 34% of its $255M portfolio in Q4 2022.
- Mark Hillman opened 5 new positions and closed 1 in Q4 2022.
- Mark Hillman's portfolio value rose 5.7% quarter-over-quarter to $255M.
Based on Hillman Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.